UK Markets close in 58 mins

Applied DNA Sciences, Inc. (APDN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2700-0.1200 (-8.63%)
As of 04:00PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.99
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 38.1000
52-week low 31.0800
50-day moving average 31.7894
200-day moving average 33.9599

Share statistics

Avg vol (3-month) 366.59k
Avg vol (10-day) 336.55k
Shares outstanding 57.49M
Implied shares outstanding 6N/A
Float 87.35M
% held by insiders 12.37%
% held by institutions 17.42%
Shares short (28 Apr 2022) 4285.97k
Short ratio (28 Apr 2022) 46.66
Short % of float (28 Apr 2022) 43.55%
Short % of shares outstanding (28 Apr 2022) 43.47%
Shares short (prior month 30 Mar 2022) 4269.36k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 331 Oct 2019
Ex-dividend date 4N/A
Last split factor 21:40
Last split date 331 Oct 2019

Financial highlights

Fiscal year

Fiscal year ends 29 Sept 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin -122.64%
Operating margin (ttm)-120.51%

Management effectiveness

Return on assets (ttm)-82.73%
Return on equity (ttm)-201.10%

Income statement

Revenue (ttm)11.58M
Revenue per share (ttm)1.56
Quarterly revenue growth (yoy)157.80%
Gross profit (ttm)4.93M
EBITDA -12.88M
Net income avi to common (ttm)-14.2M
Diluted EPS (ttm)-2.0700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.75M
Total cash per share (mrq)0.37
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)2.85
Book value per share (mrq)1.49

Cash flow statement

Operating cash flow (ttm)-12.93M
Levered free cash flow (ttm)-9.91M